Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group study

Journal of Clinical Oncology

Volumn 17, Issue 7, 1999, Pages 2127-2136

  Packer, Roger J ^a   Goldwein, Joel ^b   Nicholson, H Stacy ^b   Vezina, L Gilbert ^b   Allen, Jeffrey C ^b   Ris, M Douglas ^b   Muraszko, Karin ^b   Rorke, Lucy B ^b   Wara, William M ^b   Cohen, Bruce H ^b   Boyett, James M ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; LOMUSTINE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHICKENPOX; CHILD; CLINICAL PROTOCOL; COGNITION; ENDOCRINE SYSTEM; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; SEPSIS; TREATMENT OUTCOME;

EID: 0033056823     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.7.2127     Document Type: Article

References (28)

1. Packer RJ, Sutton LN, D'Angio G, et al: Management of children with primitive neuroectodermal tumors of the posterior fossa/ medulloblastoma. Pediatr Neurosci 12:272-282, 1985-86
2. Evans AE, Jenkin RDT, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990
3. Packer RJ, Sutton LN, Elterman R, et al: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 81:690-698, 1994
4. Zeltzer P, Boyett J, Finlay J, et al: Prognostic factors for survival in high risk primitive neuroectodermal tumors (PNETs) in children: Report from the Childrens Cancer Group CCG-921. Proc Am Soc Clin Oncol 12:415, 1993 (abstr)
5. Tait DM, Thorton-Jones H, Bloom HJG, et al: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control of the International Society of Paediatric Oncology (SIOP). Eur J Cancer 26:464-469, 1990
6. McIntosh S, Chen M, Sartain PA, et al: Adjuvant chemotherapy for medulloblastoma. Cancer 56:1316-1319, 1985
7. Packer RJ: Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28:823-828, 1990
8. Packer RJ, Sutton LN, Atkins TE, et al: A prospective study of cognitive function in children receiving wholebrain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70:707-713, 1989
9. Deutsch M, Thomas PR, Krischer J, et al: Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3600 cGy/20) with reduced neuroaxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma: A combined Children's Cancer Group-Pediatric Oncology Group study. Pediatr Neurosurg 24:167-177, 1996
10. Bailey CC, Gnekow A, Welleks: Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma: International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO) - SIOP II. Med Pediatr Oncol 25:166-178, 1995
11. National Cancer Institute: Cancer Therapy Evaluation Program: Common Toxicity Criteria (version 2.0). Bethesda, MD, Division of Cancer Treatment, National Cancer Institute. March 1998
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 54:457-481, 1958
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I. Introduction and design. Br J Cancer 34:585-612, 1976
14. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
16. Deutsch M, Reigel DM: Myelography and cytology in treatment of medulloblastoma. Int J Radiat Oncol Biol Phys 7:721-725, 1981
17. Thomas PR, Deutsch M, Mulhern R, et al: Reduced dose vs standard dose neuraxis irradiation in low stage medulloblastoma: The POG and CCG study. Med Pediatr Oncol 25:277, 1995 (abstr)
18. Krischer JP, Ragab AH, Kun L, et al: Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:905-909, 1991
19. Prados MD, Wara W, Edwards MSB, et al: Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosoureabased chemotherapy. Pediatr Neurosurg 25:174-181, 1996
20. Jenkin D, Goddard K, Armstrong D, et al: Posterior fossa medulloblastoma in childhood: Treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 19:265-274, 1990
21. Kovnar EH, Kellie SJ, Horowitz ME, et al: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J Clin Oncol 8:330-336, 1990
22. Kretschmar CS, Tarbell NJ, Kupsky W, et al: Pre-irradiation chemotherapy for infants and children with medulloblastoma: A preliminary report. J Neurosurg 71:820-825, 1989
23. Danjoux CE, Jenkin RDT, McLaughlin J, et al: Childhood medulloblastoma in Ontario, 1977-1987: Population-based results. Med Pediatr Oncol 26:1-9, 1996
24. Brand WN, Schneider PA, Tokars RP: Long term results of a pilot study of low dose cranio-spinal irradiation for cerebellar medulloblastoma. Int J Radiat Oncol Biol Phys 13:1641-1645, 1987
25. Levin VA, Rodriguez LA, Edwards MSB, et al: Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68:383-387, 1988
26. Halbert FE, Wara WM, Fippin LF, et al: Low-dose craniospinal radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys 30:651-654, 1991
27. Prados MD, Wara WM, Edwards SB, et al: Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Early results of a pilot study. Int J Radiat Oncol Biol Phys 24:431-438, 1993
28. Goldwein JW, Radcliffe J, Johnson J, et al: Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol 34:889-904, 1996